
|Videos|March 30, 2021
Examining TKI Combinations in Advanced RCC
A panel discusses the role of TKI combination therapies for patients with advanced renal cell carcinoma and how they have changed the treatment landscape.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Breast Cancer Test Using Proteomic Profiling and AI Demonstrates High Performance
3
Varegacestat Achieves PFS Gains, Deep Shrinkage of Desmoid Tumors
4
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
5






































